Stocks · News reference
Waters Corporation and Labcorp Announce Partnership for HPV Screening
Waters Corporation and Labcorp have entered into a partnership to provide the FDA-approved BD Onclarity HPV Assay across Labcorp's U.S. laboratory network.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Overweight on Waters, Raises Price Target to $500
Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $460 to $500.
Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth
Micron, Sandisk and Nvidia lead seven S&P 500 stocks that more than doubled quarterly revenue. Six sell AI hardware.